Philips' rising market share in MR and the growth of new MR applications are helping drive incremental revenue growth for Intermagnetics General. The company is an exclusive supplier of superconducting magnets to Philips, as well as a developer of MRI
Philips' rising market share in MR and the growth of new MR applications are helping drive incremental revenue growth for Intermagnetics General. The company is an exclusive supplier of superconducting magnets to Philips, as well as a developer of MRI surface coils to multiple OEMs and end users. Second quarter results, released Jan. 8, indicate a 16% rise in earnings for the company (excluding one-time items that netted a substantial gain) to $3.6 million from $3.1 million a year earlier and a net sales increase of 20% to $39 million from $32.4 million. Sales of magnet systems and radio-frequency coils substantially increased due to continued strong demand from MR scanners, offsetting softer results in the company's instrumentation business.
On Jan. 8 the company announced the signing of a definitive agreement to sell the helium-related portion of its subsidiary IGC-APD Cryogenics' business for about $10 million. The sale to Sumitomo Heavy Industries (SHI) of Japan includes all helium-related assets and liabilities. The deal is expected to close in February 2002. The mixed-gas portion of APD Cryogenics' refrigeration systems business, currently conducted at APD's Allentown, PA, facility, will be integrated into IGC-Polycold Systems' new facility in Petaluma, CA. SHI and Intermagnetics also announced a strategic six-year supply agreement under which Intermagnetics will purchase shield coolers used in the production of its MRI magnet systems. Intermagnetics currently purchases all of its shield coolers from either SHI or APD.
New MRI Research Explores Links Between Waist-to-Hip Ratio and Memory in Aging
March 13th 2025Researchers found that a higher waist-to-hip ratio in midlife was associated with higher mean diffusivity in 26 percent of total white matter tracts in the cingulum as well as the superior and inferior longitudinal fasciculus.
Can Ultrasound-Based Radiomics Enhance Differentiation of HER2 Breast Cancer?
March 11th 2025Multicenter research revealed that a combined model of clinical factors and ultrasound-based radiomics exhibited greater than a 23 percent higher per patient-level accuracy rate for identifying HER2 breast cancer than a clinical model.